Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
05/2012
05/24/2012US20120128662 Substituted imidazoquinoxalines
05/24/2012US20120128661 Polynucleotide and polypeptide sequences involved in cancer
05/24/2012US20120128660 Diagnosis of restenosis in patients undergoing percutaneous coronary intervention
05/24/2012US20120128659 Agents capable of downregulating an msf-a - dependent hif-1alpha and use thereof in cancer treatment
05/24/2012US20120128658 Rage g82s-related methods and compositions for treating inflammatory disorders
05/24/2012US20120128657 Synthetic macrocyclic compounds and methods for treating cancer
05/24/2012US20120128656 Vaccine compositions and methods
05/24/2012US20120128627 Il-17 homologous polypeptides and therapeutic uses thereof
05/24/2012US20120128626 Anti-il-6 antibodies for the treatment of anemia
05/24/2012US20120128625 Compounds, compositions, and methods for preventing metastasis of cancer cells
05/24/2012US20120128597 Composition for prevention and treatment of allergic and/or inflammatory diseases
05/24/2012US20120128591 Anti-fap antibodies and methods of use
05/24/2012US20120128586 Method for treating chronic lymphocytic leukemia
05/24/2012US20120128585 Method of Diagnosing the presence of a tumor in a mammal by assessing CDO expression level
05/24/2012US20120128584 Anti-cdh3 antibodies labeled with radioisotope label and uses thereof
05/24/2012CA2820614A1 Respiratory syncytial virus vaccine
05/24/2012CA2818561A1 Regimens for treatments using anti-igf antibodies
05/24/2012CA2818548A1 Neutralizing anti-ccl20 antibodies
05/24/2012CA2818463A1 Luteinizing-hormone ligand and ligand-gonadotrophin complex
05/24/2012CA2818353A1 Methods and compositions for inducing an immune response to egfrviii
05/24/2012CA2818245A1 Immunoglobulin cleavage fragments vaccine compositions
05/24/2012CA2818083A1 Immunogenic compositions
05/24/2012CA2817964A1 Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viii
05/24/2012CA2817933A1 New ethiological agent
05/24/2012CA2817842A1 Combination therapy for b cell lymphomas
05/24/2012CA2817746A1 Immunostimulatory oligonucleotides
05/24/2012CA2817564A1 Preselection of subjects for therapeutic treatment based on hypoxic status
05/24/2012CA2817537A1 Fgfr1 extracellular domain combination therapies
05/24/2012CA2817250A1 Novel compositions and uses of anti-hypertension agents for cancer therapy
05/23/2012EP2455404A2 Anti-C5AR antibodies with improved properties
05/23/2012EP2455403A1 Homogeneous humanized antibodies against JAM-A that inhibit proliferation
05/23/2012EP2455402A1 Poly-N-acetyl glucosamine (PNAG/DPNAG)-binding peptides and methods of use thereof
05/23/2012EP2455401A1 Poly-N-acetyl glucosamine (PNAG/DPNAG)-binding peptides and methods of use thereof
05/23/2012EP2455400A1 Poly-N-acetyl glucosamine (PNAG/DPNAG)-binding peptides and methods of use thereof
05/23/2012EP2455399A2 Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof
05/23/2012EP2455398A2 Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof
05/23/2012EP2455102A1 Cancer therapeutic agent comprising antibody against cancer-specific membrane antigen
05/23/2012EP2455101A2 Influenza vaccine with oil-in-water emulsion adjuvant
05/23/2012EP2454364A1 Production of polio virus at high titers for vaccine production
05/23/2012EP2454284A2 Gram-positive bacteria specific binding compounds
05/23/2012EP2453921A2 Mesenchymal stem cell differentiation
05/23/2012EP2453920A2 Antagonists, uses & methods for partially inhibiting tnfr1
05/23/2012EP2453919A1 Antibodies directed to gpnmb and uses thereof
05/23/2012EP2453918A2 Rsv f protein compositions and methods for making same
05/23/2012EP2453917A1 A composition useful as rotavirus vaccine and a method therefor.
05/23/2012EP2453916A1 Supralingual vaccines and applicators
05/23/2012EP2453915A1 Treatment of infections
05/23/2012EP2453914A2 Antigen specific multi epitope -based anti-infective vaccines
05/23/2012EP2453913A1 A temperature sensitive vaccine strain of mycoplasma hyopneumoniae and uses thereof
05/23/2012EP2453912A1 Process and composition for treatment of canine and human leishmaniasis
05/23/2012EP2453911A1 Immunogenic nanomedicine composition and preparation and uses thereof
05/23/2012EP2453909A2 Antigen compositions and methods of inhibiting campylobacter jejuni bacterial infection and uses of the antigen compositions
05/23/2012EP2453902A1 Mixture of non-digestible oligosaccharides for stimulating the immune system
05/23/2012EP2453874A2 Methods for inhibiting yellow color and peroxide formation in a composition
05/23/2012EP2453871A1 Orally administered bacteria as vehicles for systemic delivery of agents
05/23/2012EP2280725B1 Vaccine for protection against haemophilus parasuis serotype 4 in piglets
05/23/2012EP2191836B1 Prophylactic or alleviating agent for peripheral nerve disorder induced by anti-cancer agent
05/23/2012EP1963482B1 Avirulent isolate of neospora caninum and its uses
05/23/2012EP1675613B1 Hiv vaccines based on env of multiple clades of hiv
05/23/2012EP1660057B1 Combination therapy for the treatment of ocular neovascular disorders
05/23/2012EP1601374B2 Compositions and methods for diagnosing and treating an inflammation
05/23/2012EP1567641B1 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
05/23/2012EP1346059B1 Photochemical internalization for delivery of molecules into the cytosol
05/23/2012CN1898267B Modified anti-cd52 antibody
05/23/2012CN1826138B Rg1 antibodies and uses thereof
05/23/2012CN1653086B Novel peptide compositions and the use thereof in the preparation of active pharmaceutical compositions against the hepatitis C virus
05/23/2012CN102471770A Antigen peptide and use thereof
05/23/2012CN102471381A 自身免疫性脱髓鞘疾病的诊断和治疗 Self-diagnosis and treatment of demyelinating autoimmune diseases
05/23/2012CN102471380A Anti-fcrh5 antibodies and immunoconjugates and methods of use
05/23/2012CN102470172A Combination therapy of an afucosylated CD20 antibody with fludarabine and/or mitoxantrone
05/23/2012CN102470171A A complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent
05/23/2012CN102470170A Composition useful as rotavirus vaccine and a method therefor
05/23/2012CN102470169A Autoantibody production inhibitor
05/23/2012CN102470168A 新组合物 The new composition
05/23/2012CN102470167A 基于外泌体的癌症治疗 Cancer treatment based on exosomes
05/23/2012CN102465144A 柯萨奇病毒a16型病毒样颗粒疫苗 Coxsackie virus-like particle vaccine a16
05/23/2012CN102465137A 表达轮状病毒类表达颗粒的毕赤酵母、其制备方法及用途 Rotavirus class expression Pichia expression particles, their preparation and use
05/23/2012CN102464726A 淫羊藿多糖及其组分和它们用于疫苗佐剂的用途 Epimedium polysaccharide and its components and their use for vaccine adjuvants
05/23/2012CN102464721A 针对人肠道病毒71型的重组广谱性疫苗 Against human enterovirus 71 broad spectrum of recombinant vaccine
05/23/2012CN102464720A 抗血管抑素受体人鼠嵌合单克隆抗体制备及其应用 Anti-angiostatin receptor chimeric monoclonal antibody and its application
05/23/2012CN102464718A 人源化之单克隆抗体、其氨基酸序列与核苷酸序列与其用途 Humanized monoclonal antibodies, amino acid sequence and the nucleotide sequence of its use
05/23/2012CN102464705A 白念珠菌致病相关基因sfl2及其用途 Candida albicans virulence-related genes and their use sfl2
05/23/2012CN102462842A Total \ polysaccharide of isatis root, ingredients of total polysaccharide, and use of total polysaccharide and ingredients of total polysaccharide as vaccine adjuvants
05/23/2012CN102462841A 一种促进gp96蛋白的免疫活性的方法及其应用 An activity of gp96 protein to boost the immune method and its application
05/23/2012CN102462840A 乙肝治疗性疫苗 Treatment of hepatitis B vaccine
05/23/2012CN102462839A 多糖结合疫苗及其制备方法 Polysaccharide conjugate vaccine and its preparation method
05/23/2012CN102462838A 快速高效工业化生物疫苗生产系统 Fast and efficient industrialization of biological vaccine production system
05/23/2012CN102071205B Specific antigen of clonorchis sinensis and application thereof
05/23/2012CN102058879B Oral cancer nano vaccine and structuring method thereof
05/23/2012CN102038945B Method for industrially producing swine parvovirus vaccine by utilizing bioreactor
05/23/2012CN101991610B Method for structuring hepatitis E infection model
05/23/2012CN101979503B Recombinant brucella for expressing Asia type-I foot and mouth disease virus VP1 genes and method for producing vaccines thereof
05/23/2012CN101979501B Recombinant Salmonella choleraesuis for expressing surface antigen gene sao of streptococcus suis type 2, vaccine and application
05/23/2012CN101948539B IL-18 binding proteins
05/23/2012CN101934072B Method for preparing actinobacillus pleuropneumoniae (App) bacterial ghost and method for preparing subunit vaccine by loading pasteurella antigen with App bacterial ghost
05/23/2012CN101926987B Method for producing piglet paratyphoid live vaccine by using synthetic medium
05/23/2012CN101899466B Dengue virus and Japanese encephalitis virus embedded pseudo virus particle vaccine and preparation method thereof
05/23/2012CN101875913B Recombinant mycobacterium smegmatis strain capable of expressing mycobacterium tuberculosis Ag 85B and ESAT-6 fusion protein and application thereof
05/23/2012CN101870724B PLAC1 (Placenta-specific 1) anti-tumor CTL (Cytotoxic T Lymphocyte) epitope peptide and application thereof
05/23/2012CN101820870B Uses of trientine and penicillamine as countermeasures to metal contamination
1 ... 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 ... 1823